ASSOCIATIONS BETWEEN SERUM FOLIC ACID LEVEL AND THE RISK OF ENDOMETRIAL HYPERPLASIA IN PERIMENOPAUSE

FARIDA V. ABDIYEVA
In: EXPERIMENTAL & CLINICAL MEDICINE GEORGIA · 2023 · doi:10.52340/jecm.2023.05.37 · W4387640341
article OA: bronze CC0
🔓 Open OA copy View on OpenAlex View at publisher

Abstract

The results of our study demonstrated that endometrial hyperplasia was also characterized by unchanged levels of folic acid. The findings of our study are necessary in understanding the significance and role of vitamins in the endometrial hyperplasia. We found that folic acid administration for 8 weeks at a dosage of 1 mg/d for women with EH improved vasomotor symptoms. This suggests that folic acid supplementation may have advantageous therapeutic potential for women with EH.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (7)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK